ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
95,658.62
-3.67%
S&P 500
6,040.13
1.11%
Dow Jones
43,329.55
0.08%
US Dollar vs Yen
157.9105
0.48%
Brent Oil
72.985
-0.41%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. CG Oncology Inc (CGON) 銘柄情報

CG Oncology Inc

CG Oncology Inc (CGON)

NASDAQ
28.97
0.67
( 2.37% )
更新日時： 03:39:44
15分遅延

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
28.97
買値
28.88
売値
29.10
出来高
168,753
27.82 日の範囲 29.25
25.77 52 週間の範囲 50.23
時価総額
1.959B
前日終値
28.30
始値
28.06
時刻
1
@
28.91
最終取引時間
03:39:58
財務取引量
US$ 4,837,354
VWAP
28.6653
平均取引量 (3 か月)
594,151
発行済株式数
67,629,675
配当利回り
-
PER
-28.91
1 株当たり利益 (EPS)
-1
歳入
204k
純利益
-67.8M

CG Oncology Inc について

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live ... CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
cgoncology.com
本社
Dover, Delaware, USA
設立
-
CG Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker CGON. The last closing price for CG Oncology was US$28.30. Over the last year, CG Oncology shares have traded in a share price range of US$ 25.77 to US$ 50.23.

CG Oncology currently has 67,629,675 shares in issue. The market capitalisation of CG Oncology is US$1.91 billion. CG Oncology has a price to earnings ratio (PE ratio) of -28.91.

CGON 最新ニュース

その他のニュース

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月18日
Edgar (US Regulatory)

CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

IRVINE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

2024年12月17日
GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]

2024年12月14日
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

2024年12月13日
Edgar (US Regulatory)

CG Oncology Announces Pricing of Public Offering

IRVINE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

2024年12月13日
GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

2024年12月12日
Edgar (US Regulatory)

CG Oncology Announces Proposed Public Offering

IRVINE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

2024年12月11日
GlobeNewswire Inc.

SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

SCHAUMBURG, Ill. and IRVINE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and...

2024年12月6日
GlobeNewswire Inc.

Form 8-K - Current report

2024年12月5日
Edgar (US Regulatory)

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

– 74.5% of patients achieved a complete response at any time – – Median duration of response is greater than 27 months and not reached – – Latest data update continued to show favorable safety...

2024年12月5日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.351.2229210342428.6229.252792066028.31373991CS
4-5.27-15.391355140234.2436.732798206030.49378781CS
12-7.17-19.83951300536.1440.472759415133.02580161CS
26-2.17-6.9685292228631.1440.472765659634.67243524CS
52-0.03-0.1034482758622950.2325.7767789335.56027599CS
156-0.03-0.1034482758622950.2325.7767789335.56027599CS
260-0.03-0.1034482758622950.2325.7767789335.56027599CS

CGON - Frequently Asked Questions (FAQ)

What is the current CG Oncology share price?
The current share price of CG Oncology is US$ 28.97
How many CG Oncology shares are in issue?
CG Oncology has 67,629,675 shares in issue
What is the market cap of CG Oncology?
The market capitalisation of CG Oncology is USD 1.91B
What is the 1 year trading range for CG Oncology share price?
CG Oncology has traded in the range of US$ 25.77 to US$ 50.23 during the past year
What is the PE ratio of CG Oncology?
The price to earnings ratio of CG Oncology is -28.91
What is the cash to sales ratio of CG Oncology?
The cash to sales ratio of CG Oncology is 9.66k
What is the reporting currency for CG Oncology?
CG Oncology reports financial results in USD
What is the latest annual turnover for CG Oncology?
The latest annual turnover of CG Oncology is USD 204k
What is the latest annual profit for CG Oncology?
The latest annual profit of CG Oncology is USD -67.8M
What is the registered address of CG Oncology?
The registered address for CG Oncology is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the CG Oncology website address?
The website address for CG Oncology is cgoncology.com
Which industry sector does CG Oncology operate in?
CG Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AIREreAlpha Tech Corporation
US$ 3.425
(150.00%)
108.45M
SPRCSciSparc Ltd
US$ 0.4904
(121.70%)
221.83M
MGIHMillennium Group International Holdings Ltd
US$ 3.095
(102.29%)
72.56M
BCGBinah Capital Group Inc
US$ 3.81
(92.42%)
8.08M
ZCARZoomcar Holdings Inc
US$ 2.69
(88.11%)
56.24M
LNKSLinkers Industries Ltd
US$ 2.94
(-69.34%)
1.61M
BAOSBaosheng Media Group Holdings Ltd
US$ 4.22
(-40.56%)
1.52M
GTIGraphjet Technology
US$ 0.4268
(-30.03%)
15.53M
NEUPNeuphoria Therapeutics Inc
US$ 4.65
(-29.86%)
502.08k
SVRESaverOne 2014 Ltd
US$ 1.0801
(-28.47%)
1.1M
SPRCSciSparc Ltd
US$ 0.4904
(121.70%)
221.83M
XTIAXTI Aerospace Inc
US$ 0.0401
(2.30%)
201.34M
COEPCoeptis Therapeutics Holdings Inc
US$ 0.2081
(46.55%)
193.12M
RGTIRigetti Computing Inc
US$ 14.4126
(26.98%)
158.83M
SMXSMX Security Matters Public Company
US$ 0.35
(60.55%)
157.23M

CGON Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
CGON
CG Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有